Low-molecular but not high-molecular advanced glycation end products (AGES) are removed by high-flux dialysis

Clinical Nephrology

Volumn 54, Issue 4, 2000, Pages 276-283

  Gerdemann, A ^a   Lemke, H D ^a   Nothdurft, A ^a   Heidland, A ^a   Munch, G ^a   Bahner, U ^a   Schinzel, R ^a  

^a Physiologische Chemie I   (Germany)

Author keywords

Advanced glycation; End stage renal disease; Endproducts (AGEs); High flux dialysis

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BETA 2 MICROGLOBULIN;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIALYSIS MEMBRANE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE SPECTROSCOPY; GEL FILTRATION; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MALE; MOLECULAR WEIGHT; NEPHELOMETRY; NEPHROTOXICITY; UREMIA;

ADULT; BETA 2-MICROGLOBULIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMAN; KIDNEY FAILURE, CHRONIC; MIDDLE AGE; MOLECULAR WEIGHT; RENAL DIALYSIS; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0033770156     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. 2-microglobulin concentration after cuprophan haemodialysis
2. Glycosylation products as toxic mediators of diabetic complications
3. Advanced protein glycosylation in diabetes and ageing
4. Advanced glycosylation: Chemistry, biology and implicatons for diabetes and ageing
5. Immunological determination of advanced glycation endproducts in human blood and urine
6. Influence of dialysis modality on plasma and tissue concentrations of pentosidine in patients with end-stage renal disease
7. Possible significance of advanced glycation end products in serum in end-stage renal disease and in complications of diabetes
8. Advanced glycation end-products (AGE) during haemodialysis treatment: Discrepant results with different methodologies reflecting the heterogeneity of AGE compounds
9. Influence of hemodialysis membrane type on pentosidine plasma level, a marker of 'carbonyl stress'
10. Advanced glycosylation endproducts in patients with diabetic nephropathy
11. Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure
12. Pathophysiology of advanced glycation endproducts in renal failure
13. Clearance of pentosidine, an advanced glycation endproduct, by different modalities of renal replacement therapy
14. Nonenzymatic browning in vivo: Possible process for ageing of long-lived proteins
15. Structure of advanced Millard reaction products and their pathological role
16. Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitve ELISA
17. Amyloid beta-(2)-microglobulin is modified with imidazolone, a novel advanced glycation endproduct, in dialysis-related amyloidosis
18. Relationships between glycation and oxidation related fluorescence in rat collagen daring ageing-an in vivo and in vitro study
19. Plasma advanced glycosylation end-products in maintenance haemodialysis patients
20. Immunological quantification of advanced glycosylation endproducts in the serum of patients on haemodialysis or CAPD
21. Biology of disease. Pathogenic effects of advanced glycosylation: Biochemical, biologic and clinical implications for diabetes and ageing
22. Advanced glycation endproducts induce glomerular sclerosis and albuminuria in normal rats